AIM ImmunoTech's total assets for Q4 2025 were $5.78M, a decrease of -32.65% from the previous quarter. AIM total liabilities were $15.56M for the fiscal quarter, a 140.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.